การตรวจตราด้านชีวสมมูล และการเขียน Corrective and Preventive Action (CAPA) (ตอนที่ 2)
Article Sidebar
Main Article Content
Article Details
อนุญาตภายใต้เงื่อนไข Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เอกสารอ้างอิง
1.European Medicines Agency. Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHMP. London: European Medicines Agency; 2012. (EMA/INS/GCP/46309/2012).
2.Food and Drug Administration (FDA). 21 CFR Part 820. Quality System Regulation. 1996.
3.Bersbach W. The Corrective Action Process: A Step-by-Step Guide. Quality Progress. 2007;40(9):24-31.
4.Siew PW, Al Japar MF, Abdullah S, Lim SL, Tan CT. Customer complaints management in pharmaceutical industries: a systematic review. Int J Pharm Qual Assur. 2021;12(1):1-8.
5.Wheeler DJ, Chambers DS. Understanding Statistical Process Control. 3rd ed. Knoxville: SPC Press; 2004.
6.Tague NR. The quality toolbox. 2nd ed. Milwaukee, WI: ASQ Quality Press; 2005. p. 247–56.
7.Juran JM, Godfrey AB. Juran's quality handbook. 5th ed. New York: McGraw-Hill; 1999.
8.Liker JK. The Toyota way: 14 management principles from the world's greatest manufacturer. New York: McGraw-Hill; 2004.
9.Ohno T. Toyota production system: beyond large-scale production. Portland, OR: Productivity Press; 1988.
10.Goetsch DL, Davis SB. Quality Management for Organizational Excellence: Introduction to Total Quality. 7th ed. Boston: Pearson; 2013.
11.Wheeler DJ. Understanding variation: the key to managing chaos. 2nd ed. Knoxville (TN): SPC Press; 2000.
12.Tahan A. The importance of CAPA system in pharmaceutical industry. Int J Pharm Qual Assur. 2018;9(2):17-21.
13.Montgomery DC. Introduction to Statistical Quality Control. 7th ed. Hoboken: John Wiley & Sons; 2013.
14.Deming WE. The New Economics for Industry, Government, Education. 2nd ed. Cambridge, MA: MIT Press; 2000.
15.U.S. Food and Drug Administration (FDA). Compliance Program Guidance Manual (CPGM) 7346.832: Bioequivalence (BE) Inspections. 2020.
16.EudraLex Volume 4. Good Manufacturing Practice (GMP) guidelines. 2022.
17.World Health Organization (WHO). Good manufacturing practices for pharmaceutical products. WHO Technical Report Series, No. 908, Annex 4. Geneva: World Health Organization; 2003.
18.International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Q9: Quality Risk Management. 2005.
19.Besterfield DH, Besterfield-Michna C, Besterfield GH, Besterfield-Sacre M. Total Quality Management. 3rd ed. Upper Saddle River, NJ: Pearson Prentice Hall; 2005.
20.Rooney JJ, Vanden Heuvel LN. Root Cause Analysis for Beginners. Quality Progress. 2004;37(7):45-53.
21.American Society for Quality (ASQ). Corrective and Preventive Action (CAPA). [cited 2025 October 23]. Available from: https://asq.org/quality-resources/corrective-preventive-action.
